🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery ◆ GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons ◆ Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing ◆
Updated 13 Sep 2026 · ClinicalTrials.gov

Clinical Trials in New York

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

24
Recruiting now
37
Studies tracked
New York
Selected state
Active Phase 1
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
Non-hodgkin Lymphoma
Genmab · started 2022-10-04
California · Florida · New York · North Carolina · Ohio · Pennsylvania · Tennessee · Texas
NCT05206357 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Amgen · started 2023-11-16
California · Delaware · Florida · Illinois · Kentucky · Massachusetts · New Mexico · New York
NCT05920356 on ClinicalTrials.gov ↗
Active
Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma
Carcinoma, Hepatocellular, Cirrhosis, Liver
Glycotest, Inc. · started 2019-05-22
California · Florida · Illinois · Maryland · Michigan · Minnesota · New York · Pennsylvania
NCT03878550 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies
Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor, Platinum-resistant Ovarian Cancer
Ascendis Pharma Oncology Division A/S · started 2022-01-11
California · Illinois · Kentucky · Massachusetts · New Jersey · New York · North Carolina · Ohio
NCT05081609 on ClinicalTrials.gov ↗
Active
Myopia Control With a Innovative Spectacle Lens - A Cessation Study
Myopia Progressing
Essilor International · started 2025-02-18
Illinois · Kansas · Massachusetts · New York
NCT06884527 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
LMN-201 for Prevention of C. Difficile Infection Recurrence
Clostridioides Difficile Infection
Lumen Bioscience, Inc. · started 2024-08-29
California · Connecticut · Florida · Illinois · Kentucky · Michigan · Minnesota · New York
NCT05330182 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Ovarian Cancer, Non-small Cell Lung Cancer
Tubulis GmbH · started 2024-06-12
Alabama · Connecticut · Georgia · Kentucky · Massachusetts · New Jersey · New York · Ohio
NCT06303505 on ClinicalTrials.gov ↗
Recruiting
The PERSEVERE Study
Pulmonary Embolism, Pulmonary Thromboembolism
Inari Medical · started 2024-12-16
Connecticut · Florida · Georgia · Mississippi · New York · Ohio · Pennsylvania · Tennessee
NCT06588634 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Crohn's Disease
Sanofi · started 2024-12-10
Arizona · Connecticut · Florida · Illinois · Michigan · Mississippi · Nevada · New York
NCT06637631 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Bladder Cancer
Merck Sharp & Dohme LLC · started 2026-04-23
District of Columbia · Maryland · Michigan · New Jersey · New York · North Carolina · Ohio · Tennessee
NCT07419295 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia
Astellas Pharma Global Development, Inc. · started 2023-01-31
California · Colorado · Florida · Illinois · Maryland · New York · North Carolina · Ohio
NCT05520567 on ClinicalTrials.gov ↗
Active Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)
Non-small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC · started 2024-06-11
California · Florida · Georgia · Michigan · Missouri · New Jersey · New York · North Dakota
NCT06305754 on ClinicalTrials.gov ↗
Recruiting Phase 2
A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
Primary Membranous Nephropathy
AstraZeneca · started 2026-03-28
California · Iowa · Maryland · New York · Texas
NCT07571746 on ClinicalTrials.gov ↗
Active Phase 2
Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis
Gilead Sciences · started 2023-12-05
Arizona · California · Florida · Michigan · Minnesota · Mississippi · Missouri · New York
NCT06029972 on ClinicalTrials.gov ↗
Recruiting Phase 3
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
Obesity, Overweight, Obstructive Sleep Apnoea
Novo Nordisk A/S · started 2026-05-05
California · Florida · Georgia · Illinois · New York · Ohio · Pennsylvania · Texas
NCT07571005 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Metastatic Soft Tissue Sarcoma, Unresectable Soft Tissue Sarcoma
Adcendo ApS · started 2025-06-05
Colorado · Florida · New York · Texas
NCT06797999 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Castration-Resistant Prostatic Cancer, Metastasis
Merck Sharp & Dohme LLC · started 2025-07-03
California · District of Columbia · Michigan · New York · Pennsylvania · Tennessee · Washington
NCT06863272 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Advanced Solid Tumors, HNSCC, SCLC, NSCLC
Tubulis GmbH · started 2024-12-13
Connecticut · Florida · Massachusetts · Minnesota · Missouri · New York · Ohio · Texas
NCT06657222 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Ocular Myasthenia Gravis
UCB Biopharma SRL · started 2026-05-27
Arizona · Illinois · New York · Ohio · Wisconsin
NCT07463521 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Follicular Lymphoma (FL)
Regeneron Pharmaceuticals · started 2023-12-12
Arizona · California · Indiana · Massachusetts · Michigan · Mississippi · New York · North Carolina
NCT06091254 on ClinicalTrials.gov ↗
Active
Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
Tachycardia, Ventricular, Arrhythmia, Ventricular
Boston Scientific Corporation · started 2021-07-20
Arizona · Arkansas · Florida · Georgia · Kentucky · Minnesota · New Jersey · New York
NCT04798768 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Malignant Neoplasm
Merck Sharp & Dohme LLC · started 2026-07-06
Colorado · Iowa · Massachusetts · Michigan · New Jersey · New York · North Dakota · Pennsylvania
NCT07630974 on ClinicalTrials.gov ↗
Active Phase 2
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Colitis Ulcerative
Sanofi · started 2025-03-28
Arizona · Connecticut · Florida · Illinois · Michigan · New York · Ohio · Pennsylvania
NCT06867094 on ClinicalTrials.gov ↗
Active Phase 2/Phase 3
A Study Evaluating the Efficacy and Safety of Inavolisib + Palbociclib + Fulvestrant vs Placebo + Palbociclib + Fulvestrant in Participants With PIK3CA-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer
Breast Cancer
Hoffmann-La Roche · started 2020-01-29
California · Massachusetts · New York · North Carolina · Tennessee · Texas · Washington
NCT04191499 on ClinicalTrials.gov ↗
Recruiting Phase 2
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy), Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy), Sub-study 3 Head and Neck Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy), Sub-study 4 Esophageal Squamous Cell Carcinoma (Volrustomig in Combination With Chemotherapy)
AstraZeneca · started 2024-08-22
California · Maryland · New York · Ohio · Pennsylvania
NCT06535607 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer, Recurrent Endometrial Cancer
Regeneron Pharmaceuticals · started 2018-05-21
Alabama · Massachusetts · Minnesota · New York · Ohio · Oklahoma · Tennessee · Virginia
NCT03564340 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer, Endometrial Cancer
AstraZeneca · started 2021-10-18
California · Louisiana · Maryland · Massachusetts · Missouri · New Mexico · New York · North Carolina
NCT05123482 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Merck Sharp & Dohme LLC · started 2026-01-19
Florida · Georgia · Louisiana · Maryland · Minnesota · Nevada · New York · Ohio
NCT07216703 on ClinicalTrials.gov ↗
Recruiting Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. · started 2022-06-07
California · Illinois · Kansas · New Jersey · New York · North Carolina · Texas · Washington
NCT05365581 on ClinicalTrials.gov ↗
Recruiting
A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
Open Surgery, Lymphedema, Free Tissue Transfer, Microsurgery
MMI (Medical Microinstruments, Inc.) · started 2025-09-22
California · Connecticut · Florida · New York · Ohio
NCT06725030 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer
Pfizer · started 2026-01-30
Arkansas · California · Colorado · Florida · New Jersey · New York · Oregon · Texas
NCT07227298 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Merck Sharp & Dohme LLC · started 2025-04-15
Connecticut · Kentucky · Louisiana · Massachusetts · New York · Oklahoma · Texas · Utah
NCT06843447 on ClinicalTrials.gov ↗
Recruiting Phase 3
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC · started 2026-04-09
Georgia · Missouri · New York · Tennessee
NCT07489495 on ClinicalTrials.gov ↗
Recruiting
Clinical Performance of AH Plus Jet® Root Canal Sealers in Single-cone Protocols
Root Canal Treatment
Dentsply Sirona Implants and Consumables · started 2026-09-09
New York
NCT07642284 on ClinicalTrials.gov ↗
Active Phase 3
177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
Prostatic Neoplasms
Novartis Pharmaceuticals · started 2021-06-15
Colorado · Florida · Louisiana · Massachusetts · Missouri · Nebraska · New York · North Carolina
NCT04689828 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Multiple Myeloma
AbbVie · started 2025-07-23
California · Connecticut · Massachusetts · Michigan · New York · North Carolina · Oregon · Texas
NCT06953960 on ClinicalTrials.gov ↗
Recruiting Phase 2
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
Refractory Angina, Coronary Artery Disease
XyloCor Therapeutics, Inc. · started 2025-07-08
Alabama · Arizona · Georgia · Massachusetts · Michigan · Minnesota · New York · North Carolina
NCT07048808 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 102 Florida · 94 Illinois · 59 Georgia · 53 Arizona · 50 Colorado · 50 Texas · 40 New York · 37 Alabama · 33 Connecticut · 32 Massachusetts · 31 Michigan · 28 Ohio · 28 Indiana · 25 North Carolina · 23 Maryland · 21

Browse by condition

Breast Cancer · 5 Advanced Solid Tumor · 4 Obesity · 4 Chronic Lymphocytic Leukemia · 3 Ovarian Cancer · 3 Non-small Cell Lung Cancer · 3 Ulcerative Colitis · 3 Crohn's Disease · 3 Diffuse Large B-Cell Lymphoma · 3 Small Lymphocytic Lymphoma · 2 Urinary Bladder Neoplasms · 2 Marginal Zone Lymphoma · 2 Multiple Myeloma · 2 Pulmonary Embolism · 2 Bladder Cancer · 2 Small Cell Lung Cancer · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/new-york (Accessed: 13 September 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.